These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32739654)

  • 1. Adherence and long-term outcomes of therapy in paediatric patients in Greece using the easypod™ electromechanical device for growth hormone treatment: The phase IV multicentre easypod™ connect observational study (ECOS).
    Charmandari E; Vlachopapadopoulou E; Kyritsi EM; Sakellariou D; Koledova E; Nespithal K; Michalacos S
    Growth Horm IGF Res; 2020; 53-54():101336. PubMed ID: 32739654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS).
    Blanco-López A; Antillón-Ferreira C; Saavedra-Castillo E; Barrientos-Pérez M; Rivero-Escalante H; Flores-Caloca O; Calzada-León R; Rosas-Guerra CC; Koledova E; Chiquete E; Ayala-Estrada A
    J Endocrinol Invest; 2020 Oct; 43(10):1447-1452. PubMed ID: 32239476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of treatment adherence with growth hormone by easypod™ device: experience of an Italian centre.
    Maggio MC; Vergara B; Porcelli P; Corsello G
    Ital J Pediatr; 2018 Sep; 44(1):113. PubMed ID: 30261918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yearly Height Gain Is Dependent on the Truly Received Dose of Growth Hormone and the Duration of Periods of Poor Adherence: Practical Lessons From the French Easypod™ Connect Multicenter Observational Study.
    Coutant R; Nicolino M; Cammas B; de Buyst V; Tauber M; Hamel JF
    Front Endocrinol (Lausanne); 2021; 12():790169. PubMed ID: 35126310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ device.
    Loche S; Salerno M; Garofalo P; Cardinale GM; Licenziati MR; Citro G; Caruso Nicoletti M; Cappa M; Longobardi S; Maghnie M; Perrone R
    J Endocrinol Invest; 2016 Dec; 39(12):1419-1424. PubMed ID: 27406716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to growth hormone (GH) therapy in naïve to treatment GH-deficient children: data of the Italian Cohort from the Easypod Connect Observational Study (ECOS).
    Centonze C; Guzzetti C; Orlando G; Loche S;
    J Endocrinol Invest; 2019 Oct; 42(10):1241-1244. PubMed ID: 30968283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of treatment adherence with easypod™ in six Italian centers: a real-world experience.
    Cardinale GM; Pesce S; Ingletto D; Mariano M; Catucci A; Corciulo N; Fidotti E
    Minerva Endocrinol; 2019 Sep; 44(3):246-251. PubMed ID: 30482007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connected health for growth hormone treatment research and clinical practice: learnings from different sources of real-world evidence (RWE)-large electronically collected datasets, surveillance studies and individual patients' cases.
    Boman N; Fernandez-Luque L; Koledova E; Kause M; Lapatto R
    BMC Med Inform Decis Mak; 2021 Apr; 21(1):136. PubMed ID: 33902570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence and long-term outcomes of growth hormone therapy with easypod™ in pediatric subjects: Spanish ECOS study.
    Rodríguez Arnao MD; Rodríguez Sánchez A; Díez López I; Ramírez Fernández J; Bermúdez de la Vega JA; Yeste Fernández D; Chueca Guindulain M; Corripio Collado R; Pérez Sánchez J; Fernández González A
    Endocr Connect; 2019 Sep; 8(9):1240-1249. PubMed ID: 31484160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of adherence on growth response during the first 2 years of growth hormone treatment.
    de Arriba Muñoz A; Muñiz VC; Saez JJA; Beisti A; Llovet E; Aizpún JIL
    Endocrine; 2021 May; 72(2):513-523. PubMed ID: 33284395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone treatment adherence in prepubertal and pubertal children with different growth disorders.
    Hartmann K; Ittner J; Müller-Rossberg E; Schönau E; Stephan R; Ullrich KP; Hoppe B; Ramseger R; Brämswig J
    Horm Res Paediatr; 2013; 80(1):1-5. PubMed ID: 23860437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence and long-term growth outcomes: results from the easypod
    Koledova E; Stoyanov G; Ovbude L; Davies PSW
    Endocr Connect; 2018 Aug; 7(8):914-923. PubMed ID: 29976785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring Adherence Rate to Growth Hormone Therapy and Growth Outcomes in Taiwanese Children Using Easypod Connect: Observational Study.
    Su PH; Yang C; Chao MC; Chiang CL
    JMIR Pediatr Parent; 2021 Jan; 4(1):e14774. PubMed ID: 33448936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive Impact of Targeted Educational Intervention in Children With Low Adherence to Growth Hormone Treatment Identified by Use of the Easypod™ Electronic Auto-injector Device.
    Assefi AR; Roca F; Rubstein A; Chareca C
    Front Med Technol; 2021; 3():609878. PubMed ID: 35047902
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness and Overall Safety of NutropinAq
    Coutant R; Bosch Muñoz J; Dumitrescu CP; Schnabel D; Sert C; Perrot V; Dattani M
    Front Endocrinol (Lausanne); 2021; 12():676083. PubMed ID: 34113318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital Health in the Management of Pediatric Growth Hormone Therapy - 10 Years of Developments.
    Koledova E; Le Masne Q; Spataru A; Bagha M; Dixon D
    Stud Health Technol Inform; 2021 May; 281():926-930. PubMed ID: 34042809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-centre phase IV trial to investigate the immunogenicity of a new liquid formulation of recombinant human growth hormone in adults with growth hormone deficiency.
    Johannsson G; Nespithal K; Plöckinger U; Alam V; McLean M
    J Endocrinol Invest; 2018 Aug; 41(8):919-927. PubMed ID: 29488103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to somatotropin treatment administered with an electronic device.
    Arrabal Vela MA; García Gijón CP; Pascual Martin M; Benet Giménez I; Áreas Del Águila V; Muñoz-Rodríguez JR; Palomo Atance E
    Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(6):314-318. PubMed ID: 29680781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of real-world data on growth hormone therapy adherence using a connected injection device.
    Koledova E; Tornincasa V; van Dommelen P
    BMC Med Inform Decis Mak; 2020 Jul; 20(1):176. PubMed ID: 32727461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved adherence and growth outcomes with jet-delivered growth hormone.
    Michaelidou M; Whitten S; Bajaj P; Knight A; Spoudeas HA
    J Pediatr Endocrinol Metab; 2019 Mar; 32(3):207-213. PubMed ID: 30844762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.